hypertension | Research | Lifestyle | 10 pages | source: Nutrients | Added Jul 20, 2020
Does an intensive lifestyle modification improve early hypertension management?
This study investigated if an intensive lifestyle treatment (ILT) improves stage I hypertension. They found that ILT improved blood pressure (BP) control and arterial stiffness (AS).
hypertension | Research | 10 pages | source: Medicine | Added Jun 10, 2020
A salt substitute for hypertension – can it improve blood pressure management?
This study investigated if a salt substitute (SS) improves blood pressure (BP) control in patients with hypertension.
They found that the SS may reduce BP and medication use.
hypertension | Research | Treatment | 10 pages | source: High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension | Added Jun 07, 2020
Does single pill administration improve clinical outcomes with treatment for hypertension and high cholesterol?
This study investigated if a single-pill combination (SPC) improves clinical outcomes in patients with high blood pressure (BP) and high cholesterol levels.
They found that SPC improved medication adherence and outcomes of these patients.
hypertension | Research | Treatment | 10 pages | source: Lancet (London, England) | Added Jun 05, 2020
Renal denervation for the management of hypertension - can it reduce blood pressure in the absence of medication?
This study investigated if catheter-based renal denervation (CB-RD) can be used to lower blood pressure (BP) in patients not taking any medication for lowering BP.
They found that CB-RD reduces BP in patients not taking medications.
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Medicine | Added Jun 05, 2020
Conventional therapy combined with moxibustion improves urinary symptoms in patients with benign prostate hyperplasia
This study investigated the effectiveness of moxibustion in addition to conventional therapy for benign prostatic enlargement (BPE). Researchers suggested that moxibustion might be a good addition in the treatment of these patients.
hypertension | Research | 10 pages | source: Medicine | Added Jun 03, 2020
How effective are mobile health apps in managing hypertension?
This study investigated if mobile health applications (MHA) improve blood pressure (BP) management. They found that MHA could improve BP management by increasing treatment adherence.
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Medicine | Added Jun 03, 2020
Mirabegron improves the treatment outcomes of patients with overactive bladder and benign prostatic hyperplasia receiving tamsulosin
This study investigated the effectiveness of mirabegron (Myrbetriq) on overactive bladder (OAB) in patients with benign prostatic hyperplasia (BPH) receiving tamsulosin (Flomax) therapy. Researchers suggested that mirabegron is a good and safe treatment for these patients.
erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Jun 02, 2020
How effective are pelvic floor muscle exercises for patients with erectile dysfunction following prostate removal?
This study examined if pelvic floor muscle exercises (PFME) were useful to treat patients with erectile dysfunction (ED) following surgical removal of the prostate. The results suggested that PFME may help patients with ED.
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Jun 01, 2020
What is the effect of silodosin on sexual function in men with benign prostatic hyperplasia?
This study aimed to investigate the effects of silodosin (Rapaflo) on sexual function in men with benign prostatic hyperplasia (BPH). The main finding was that silodosin improved erectile function for most participants.
hypertension | Research | 10 pages | source: Hypertension (Dallas, Tex. : 1979) | Added Jun 01, 2020
Antihypertensive drugs in COVID-19: are there benefits associated with ARB/ACEi drugs?
This study investigated if blood pressure drugs that target the angiotensin-converting enzyme (ACE) affect COVID-19 outcomes.
They found that ACE drugs were not associated with worse outcomes in COVID-19.
